ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $56,000 | -46.2% | 10,335 | -57.1% | 0.26% | +4216.7% |
| Q1 2019 | $104,000 | -89.1% | 24,111 | -71.6% | 0.01% | -84.2% |
| Q1 2018 | $953,000 | +197.8% | 84,925 | +116.9% | 0.04% | +137.5% |
| Q3 2017 | $320,000 | +196.3% | 39,158 | +62.4% | 0.02% | +166.7% |
| Q2 2017 | $108,000 | -41.9% | 24,108 | -28.6% | 0.01% | -33.3% |
| Q1 2017 | $186,000 | +6.3% | 33,773 | +56.4% | 0.01% | +12.5% |
| Q1 2016 | $175,000 | -34.0% | 21,600 | -1.8% | 0.01% | -38.5% |
| Q4 2015 | $265,000 | – | 22,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $2,341,000 | 3.33% |
| Matrix Capital Management Company, LP | 38,974,185 | $66,256,000 | 1.50% |
| NEA Management Company, LLC | 17,082,612 | $29,040,000 | 1.49% |
| Endurant Capital Management LP | 1,824,065 | $3,101,000 | 1.09% |
| Long Focus Capital Management, LLC | 4,679,491 | $7,955,000 | 0.83% |
| Key Client Fiduciary Advisors, LLC | 416,166 | $707,000 | 0.69% |
| PFM Health Sciences, LP | 9,109,780 | $15,487,000 | 0.59% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $153,000 | 0.21% |
| DAFNA Capital Management LLC | 351,064 | $597,000 | 0.16% |
| Rock Springs Capital Management LP | 2,357,544 | $4,008,000 | 0.12% |